Skip to content
CoreReview

Zimbabwe Rejects ‘Unbalanced’ American Health Aid Package Because of Information Concerns

Health funding illustration
The offered American funding was aimed at programmes for HIV/Aids treatment and prevention, TB, and malaria.

The nation of Zimbabwe has rejected a major US health deal worth $367m (£272m) spanning five years over Washington's insistence on confidential biological samples.

The decision came to light after a government memo dated December was leaked, revealing that Head of State Emmerson Mnangagwa felt the arrangement was "lopsided".

An official representative has since clarified that the US was requesting health data for scientific study and commercial gain while refused to guarantee the benefits from any future medical innovations.

"We must now begin the challenging and unfortunate process of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the United States had donated over $1.9bn as health assistance to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has appealed for more negotiations to secure a agreement acceptable to all parties so the nation's vital HIV treatment initiative can proceed.

Wider Context

Zimbabwe's decision follows a comparable situation in neighbouring Kenya, where a court blocked a similar health funding agreement after legal challenges were raised about the security of citizens' medical information.

After returning to office recently, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).

The agency had managed aid for the US government, but Trump argued its expenditure was "wasteful" and his administration was seeking government-to-government deals to boost openness and accountability.

Based on statements, 16 nations in Africa have so far signed similar agreements, representing over $18.3bn in new funding.

Details of the Rejected Agreement

The money for Zimbabwe was intended to gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We believe this collaboration might have yielded immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently on antiretroviral therapy through US-supported programmes," Tremont said.

However, government spokesperson Nick Mangwana argued the arrangement was "unequal".

"Zimbabwe was being asked to provide its genetic material and health information over an extended period, with no equivalent guarantee of benefiting from any medical innovations – such as new medicines or tests – that could be developed from that shared data," Mangwana explained.

"In essence, our country would provide the basic resources for medical research with no assurance that the resulting innovations would be accessible to our citizens should a new health crisis arise."

Sovereignty and Global Health

He also noted that the American exit from the global health body and its pursuit of bilateral deals were undermining structures previously set up through the global health agency.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework created to deal with potential global health emergencies.

"This mechanism is designed to guarantee that when a nation provides its data, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the resources to create them."

Zimbabwe's reservations over the US deal "should not be misconstrued as anti-American sentiment," he added.

"We are open to continued discussions with our American counterparts on how subsequent co-operation could be arranged in a manner that honours the sovereignty and dignity of each country."

Medical Community Reaction

Medical experts said it acknowledged the government's concerns, but recommended that negotiations must proceed considering much of the nation's Aids initiatives were funded by international support.

"In cases where specific concerns exist, such as those involving information security or agreement terms, these can frequently be addressed via detailed discussion and negotiated safeguards," the group added.

The halted deal highlights the continuing challenges between receiving vital foreign assistance and safeguarding national sovereignty in an increasingly data-driven world.

By

Jill Dunn

A tech journalist with a passion for exploring innovative gadgets and digital culture, based in San Francisco.

CoreReview

Type to search articles.